1,3-Dipolar cycloaddition of nitrilimines to 2,4-disubstituted-3H-1, 5-benzodiazepines: Remarkable effect of C4-substituent on diastereoselectivity

New Journal of Chemistry

Volumn 27, Issue 11, 2003, Pages 1644-1648

  Nabih, Khadija ^a   Baouid, Abdesselam ^a   Hasnaoui, Aissa ^a   Selkti, Mohamed ^b   Compain, Philippe ^c  

^a CADI AYYAD UNIVERSITY   (Morocco)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Université d'Orléans   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHYL 3H 1,5 BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BIS 1,2,4 TRIAZOLO[4,3 A:3',4' D][1,5]BENZODIAZEPINE; IMINE; NITRILIMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CYCLOADDITION; DIASTEREOISOMER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

EID: 0345059736     PISSN: 11440546     EISSN: None     Source Type: Journal    
DOI: 10.1039/b303995c     Document Type: Article

References (35)

1. G. A. Archer and L. H. Sternbach, Chem. Rev., 1968, 68, 747.
2. T. A. Hamor and I. L. Martin in Progress in Medicinal Chemistry, eds. G. P. Ellis and G. B. West, Elsevier Science Publishers, Amsterdam, 1983, vol. 20.
3. R. Langnickel, R. Bluth and T. Ott, Pharmazie, 1986, 41, 689.
4. A. L. Parola, H. I. Yamamura and H. E. Laird, Life Sci., 1993, 52, 1329.
5. S. Michelini, G. B. Cassano, F. Frare and G. Perugi, Pharmacopsychiatry, 1996, 29, 127.
6. (a) J. Knabe, H. P. Buech and S. Bender, Arch. Pharm., 1995, 328, 59;
7. (b) R. N. Brogden, R. C. Heel, T. M. Speight and G. S. Avery, Drugs, 1980, 20, 161.
8. K. S. Atwal, J. L. Bergey, A. Hedberg and S. Moreland, J. Med. Chem., 1987, 30, 635.
9. (a) V. Merluzzi, K. D. Hargrave, M. Labadia, K. Grozinger, M. Skoog, J. C. Wu, C.-K. Shih, K. Eckner, S. Hattox, J. Adams, A. S. Rosenthal, R. Faanes, R. J. Eckner, R. A. Koup and J. L. Sullivan, Science, 1990, 250, 1411;
10. (b) M. Di Braccio, G. Grossi, G. Roma, L. Vargiu, M. Mura and M. E. Marongiu, Eur. J. Med. Chem., 2001, 36, 935.
11. (a) W. Werner, J. Baumgart, G. Burckhardt, W. F. Fleck, K. Geller, W. Gutsche, H. Hanschmann, A. Messerschmidt and W. Roemer, Biophys. Chem., 1990, 35, 271;
12. (b) D. A. Claremon, N. Liverton, H. G. Selnick and G. R. Smith, PCT Int. Appl. WO 9640653.
13. For a presentation of the concept of "privileged scaffold" see B. E. Evans, K. E. Rittle, M. G. Bock, R. M. DiPardo, R. M. Freidinger, W. L. Whitter, G. F. Lundell, D. F. Veber and P. S. Anderson, J. Comb. Chem., 2000, 5, 513.
14. M. E. Tranquillini, P. G. Cassara, M. Corsi, G. Curotto, D. Donati, G. Finizia, G. Pentassuglia, S. Polinelli, G. Tarzia, A. Ursini and F. T. M. Van Amsterdam, Arch. Pharm., 1997, 330, 353.
15. M. J. Batchelor, D. Bebbington, G. W. Bemis, W. H. Fridman, R. J. Gillespie, J. M. C. Golec, D. J. Lauffer, D. J. Livingston, S. S. Matharu, M. D. Mullican, M. A. Murcko, R. Murdoch, and R. E. Zelle, PCT US Appl. US96-598332.
16. J. A. Barltrop, C. G. Richards, D. M. Russel and G. J. Ryback, J. Chem. Soc., 1959, 1132.
17. S. L. Schreiber, Science, 2000, 287, 1964.
18. It has been shown that the addition of fused 5-membered heterocycles onto 1,4-benzodiazepines increases their CNS depressant activity. J. B. Hester Jr., A. D. Rudzik and B. V. Kamdar, J. Med. Chem., 1971, 14, 1078.
19. (a) A. Baouid, S. Elhazazi, A. Hasnaoui, P. Compain, J.-P. Lavergne and F. Huet, New J. Chem., 2001, 25, 1479;
20. (b) M. Essaber, A. Baouid, A. Hasnaoui, A. Benharref and J.-P. Lavergne, Synth. Commun., 1998, 28, 4097;
21. (c) R. Benelbaghdadi, A. Hasnaoui, J.-P. Lavergne, M. Giorgi and M. Pierrot, Synth. Commun., 1998, 28, 4221;
22. (d) A. Baouid, A. Benharref, A. Hasnaoui and J.-P. Lavergne, Bull. Soc. Chim. Belg., 1994, 103, 743;
23. (e) R. Jalal, M. El Messaoudi, A. Hasnaoui, M. Esseflar, M. Selkti, J.-P. Lavergne and P. Compain, New J. Chem., 2002, 26, 1545.
24. For a review on nitrilimines see G. Bertrand and C. Wentrup, Angew. Chem., Int. Ed. Engl., 1994, 33, 527.
25. B. Sharp and C. S. Hamilton, J. Am. Chem. Soc., 1946, 68, 588.
26. M. Begtrup, J. Elguero, R. Faure, P. Camps, C. Estopa, D. Ilavsky, A. Fruchier, C. Marzin and J. Mendoza, Magn. Reson. Chem., 1988, 26, 134.
27. (a) J. Bastide and O. Henri-Rousseau, Bull. Chem. Soc. Fr., 1973, 2290;
28. (b) K. N. Houk, J. Sims, R. E. Duke Jr., R. W. Strozier and J. K. George, J. Am. Chem. Soc., 1973, 95, 7301.
29. For a related example of anti addition see M. C. Aversa, P. Bonaccorsi, P. Giannetto and D. A. Leigh, J. Heterocycl. Chem., 1989, 26, 1619.
30. 24.
31. G. M. Sheldrick, SHELXS-97, Program for solution of crystal structures, University of Göttingen, Germany. 1997.
32. G. M. Sheldrick and T. R. Schneider, SHELXL, High resolution refinement, in Methods in Enzymology, 277, eds. C. W. Carter, Jr and L. M. Sweet, Academic Press, San Diego, 1997, pp. 319-343.
33. H. Tucker and D. J. Le Count, Comprehensive Heterocyclic Chemistry II, eds. A. R. Katritzky, C. W. Rees and E. F. V. Scriven, Elsevier Science Inc.; New York, 1996, Vol. 9, pp. 151-182.
34. For a recent review on the combinatorial synthesis of bicyclic privileged scaffold including 1,5-benzodiazepine-2-ones see D. A. Horton, G. T. Bourne and M. L. Smythe, Chem. Rev., 2003, 103, 893.
35. R. Huisgen, M. Seidel, G. Wallbillich and H. Knupfer, Tetrahedron, 1962, 17, 3.